Acurx Pharmaceuticals Statistics

Total Valuation

ACXP has a market cap or net worth of $6.53 million. The enterprise value is -$2.72 million.

Market Cap	6.53M
Enterprise Value	-2.72M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026, before market open.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

ACXP has 4.30 million shares outstanding. The number of shares has increased by 122.82% in one year.

Current Share Class	4.30M
Shares Outstanding	4.30M
Shares Change (YoY)	+122.82%
Shares Change (QoQ)	+25.37%
Owned by Insiders (%)	2.99%
Owned by Institutions (%)	11.81%
Float	4.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.73
P/TBV Ratio	0.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.78

Current Ratio	3.78
Quick Ratio	3.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -160.83% and return on invested capital (ROIC) is -102.30%.

Return on Equity (ROE)	-160.83%
Return on Assets (ROA)	-66.50%
Return on Invested Capital (ROIC)	-102.30%
Return on Capital Employed (ROCE)	-108.82%
Weighted Average Cost of Capital (WACC)	-7.22%
Revenue Per Employee	n/a
Profits Per Employee	-$1.87M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.58% in the last 52 weeks. The beta is -2.09, so ACXP's price volatility has been lower than the market average.

Beta (5Y)	-2.09
52-Week Price Change	-86.58%
50-Day Moving Average	1.89
200-Day Moving Average	3.34
Relative Strength Index (RSI)	37.61
Average Volume (20 Days)	71,718

Short Selling Information

The latest short interest is 90,033, so 2.09% of the outstanding shares have been sold short.

Short Interest	90,033
Short Previous Month	143,119
Short % of Shares Out	2.09%
Short % of Float	2.17%
Short Ratio (days to cover)	0.78

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.63M
Pretax Income	-7.50M
Net Income	-7.50M
EBITDA	n/a
EBIT	-7.63M
Earnings Per Share (EPS)	-$3.89

Full Income Statement

Balance Sheet

The company has $9.25 million in cash and n/a in debt, giving a net cash position of $9.25 million or $2.15 per share.

Cash & Cash Equivalents	9.25M
Total Debt	n/a
Net Cash	9.25M
Net Cash Per Share	$2.15
Equity (Book Value)	7.01M
Book Value Per Share	2.07
Working Capital	7.01M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.14M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-122.82%
Shareholder Yield	-122.82%
Earnings Yield	-114.78%
FCF Yield	n/a

Analyst Forecast

The average price target for ACXP is $17.00, which is 1,018.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.00
Price Target Difference	1,018.42%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 5, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Aug 5, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2